Lannett Company
LCI
#10382
Rank
โ‚ฌ6.33 M
Marketcap
0,59ย โ‚ฌ
Share price
0.00%
Change (1 day)
-72.66%
Change (1 year)

Lannett Company (LCI) - Total liabilities

Total liabilities on the balance sheet as of March 2023 : โ‚ฌ0.64 Billion

According to Lannett Company's latest financial reports the company's total liabilities are โ‚ฌ0.64 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Lannett Company - Total liabilities on balance sheet (from 2001 to 2023)

Total liabilities by year

Year Total liabilities Change
2022-06-30โ‚ฌ0.70 B17.03%
2021-06-30โ‚ฌ0.59 B-19.16%
2020-06-30โ‚ฌ0.74 B-1.19%
2019-06-30โ‚ฌ0.75 B-10%
2018-06-30โ‚ฌ0.83 B-8.66%
2017-06-30โ‚ฌ0.91 B-16.14%
2016-06-30โ‚ฌ1.08 B2594.92%
2015-06-30โ‚ฌ40.41 M15.27%
2014-06-30โ‚ฌ35.05 M17.16%
2013-06-30โ‚ฌ29.92 M-19.24%
2012-06-30โ‚ฌ37.05 M27.73%
2011-06-30โ‚ฌ29 M-28.86%
2010-06-30โ‚ฌ40.78 M22.88%
2009-06-30โ‚ฌ33.18 M9.94%
2008-06-30โ‚ฌ30.18 M17.69%
2007-06-30โ‚ฌ25.64 M7.45%
2006-06-30โ‚ฌ23.87 M11%
2005-06-30โ‚ฌ21.5 M25.91%
2004-06-30โ‚ฌ17.07 M161.7%
2003-06-30โ‚ฌ6.52 M-6.72%
2002-06-30โ‚ฌ6.99 M-54.79%
2001-06-30โ‚ฌ15.47 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
โ‚ฌ99.31 B 15,382.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ97.51 B 15,101.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚ฌ28.27 B 4,307.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ53.71 B 8,273.07%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
GlaxoSmithKline
GSK
โ‚ฌ52.63 B 8,105.35%๐Ÿ‡ฌ๐Ÿ‡ง UK